Total Payments
$774.03
2024 Payments
$157.12
Companies
7
Transactions
41
Payment Breakdown by Category
Food & Beverage$774.03 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $774.03 | 41 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $180.84 | 7 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $176.42 | 11 | $0 (2024) |
| Novo Nordisk Inc | $157.98 | 9 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $79.46 | 4 | $0 (2022) |
| Lilly USA, LLC | $72.16 | 5 | $0 (2023) |
| Dexcom, Inc. | $63.29 | 3 | $0 (2022) |
| Bayer HealthCare Pharmaceuticals Inc. | $43.88 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $157.12 | 8 | Boehringer Ingelheim Pharmaceuticals, Inc. ($70.98) |
| 2023 | $154.17 | 9 | AstraZeneca Pharmaceuticals LP ($61.45) |
| 2022 | $226.69 | 11 | Boehringer Ingelheim Pharmaceuticals, Inc. ($59.13) |
| 2021 | $236.05 | 13 | Kowa Pharmaceuticals America, Inc. ($64.03) |
All Payment Transactions
41 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: DIABETES | ||||||
| 07/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: DIABETES | ||||||
| 04/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: DIABETES | ||||||
| 02/27/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Diabetes | ||||||
| 12/08/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/24/2023 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: Diabetes | ||||||
| 09/21/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: Diabetes | ||||||
| 06/16/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/07/2023 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Diabetes | ||||||
| 05/18/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: Diabetes | ||||||
| 04/12/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/05/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: DIABETES | ||||||
| 01/11/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/27/2022 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: Diabetes | ||||||
| 08/31/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: Diabetes | ||||||
| 08/22/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: Cardio-renal | ||||||
| 08/01/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.32 | General |
| Category: DIABETES | ||||||
| 07/07/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: Cardio-renal | ||||||
| 07/06/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $31.81 | General |
| Category: DIABETES | ||||||
| 06/14/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/10/2022 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Diabetes | ||||||
About Dilleta Shackelford, APRN
Dilleta Shackelford, APRN is a Occupational Health healthcare provider based in Valdosta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/14/2010. The National Provider Identifier (NPI) number assigned to this provider is 1811209208.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dilleta Shackelford, APRN has received a total of $774.03 in payments from pharmaceutical and medical device companies, with $157.12 received in 2024. These payments were reported across 41 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($774.03).
Ad
Practice Information
- Specialty Occupational Health
- Location Valdosta, GA
- Active Since 07/14/2010
- Last Updated 07/14/2010
- Taxonomy Code 363LX0106X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1811209208
Products in Payments
- JARDIANCE (Drug) $212.69
- FARXIGA (Drug) $176.42
- Ozempic (Drug) $101.05
- Livalo (Drug) $79.46
- Rybelsus (Drug) $56.93
- Kerendia (Drug) $43.88
- DEXCOM G6 TRANSMITTER (Device) $39.49
- TRULICITY (Drug) $27.41
- Dexcom G6 Transmitter (Medical Supply) $23.80
- MOUNJARO (Drug) $12.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.